Here are three things to know:
1. The company offers platelet-rich plasma, bone void filler, demineralized bone matrix and stem cell scaffold solutions, among other products.
2. Reinvent Biologics recently appointed orthopedic surgeon David Drez Jr., MD, as CMO.
3. In 2017, the company launched its Einstein allograft bone line and expanded its Genius Concentration System product line to include a larger capacity option for blood and bone marrow aspirate processing.
More articles on biologics:
‘A new dawn’ for orthopedics: Dr. Jason Arora on the promise of biologics
Fujifilm, Cynata to collaborate on stem cell therapy trials for transplant patients: 4 insights
Hospital for Special Surgery researchers launch study of Organogenesis’ ReNu for knee defects: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
